MedTech News
.................... by Andrew Celentano
CRISPR screening identifies key targets to strengthen CAR NK cell therapies
Natural killer (NK) cells became markedly better at killing cancer cells after scientists removed key gene targets identified through a new genome-wide CRISPR screening tool, according to new research from the University of Texas MD Anderson Cancer Center.
First mechanism for cognitive disorders in schizophrenia found
https://medicalxpress.com/news/2025-08-mechanism-cognitive-disorders-schizophrenia.html
Midkine protein blocks Alzheimer’s amyloid assembly growth, scientists discover
Scientists at St. Jude Children’s Research Hospital demonstrated for the first time that the protein midkine plays a preventative role against Alzheimer’s disease.
Genetic study suggests ways to catch blood cancer earlier
As we age, our cells replicate, and the DNA in these cells can acquire mistakes—or mutations—every time the sequence is copied. Most newly acquired mutations are harmless, but some can tip the balance toward cancer development later in life.
Cold plasma penetrates deep into tissue to fight cancer
Researchers at the Leibniz Institute for Plasma Science and Technology (INP) have collaborated with partners at Greifswald University Hospital and University Medical Center Rostock to demonstrate that cold plasma can effectively combat tumor cells even in deeper tissue layers.
Boston Scientific launches head-to-head drug-coated balloon trial
Boston Scientific (NYSE: BSX)+
announced today that it initiated a new trial to assess its Agent DCB compared to the standard of care.
Ategenos Emerges from Stealth to Debut First-Ever SmartPatch Platform
Introducing the first scalable solution enabling real-time interventions for medication non-adherence
Breaking a sweat: Using chloride in sweat to help diagnose cystic fibrosis
Sweat does more than just cool down an overheating body. Measuring the chemical makeup of an individual’s sweat—specifically the levels of chloride, a chemical component of salt—can serve as an early warning system to help inform the diagnosis of cystic fibrosis, a genetic disease that damages the lungs and digestive system.